ARA-290 10mg

ARA-290, also known as Cibinetide, is a specialized peptide derived from erythropoietin (EPO), engineered to retain its tissue-protective and anti-inflammatory properties without influencing red blood cell production. This refined design has positioned ARA-290 as a standout molecule in research focused on nerve repair, inflammation modulation, and tissue protection. This peptide has ideal research in the following categories:

1. – Primary: Tissue Healing & Regeneration
2. – Primary: Nerve Health & Neuropathy Research
3. – Primary: Inflammation Control
4. – Secondary: Recovery & Cellular Protection
5. – Secondary: Longevity & Anti-Aging (cellular resilience)
   
6. – Secondary: Systemic Wellness

Understanding This Peptide

ARA-290 is an 11–amino acid peptide that mimics the protective region of erythropoietin responsible for activating innate repair mechanisms. Unlike full-length EPO, ARA-290 does not stimulate erythropoiesis, allowing researchers to isolate and study its regenerative and protective pathways without hematologic effects.

Mechanism of Action

ARA-290 binds to the innate repair receptor (IRR), a heteromeric receptor involved in tissue protection and inflammation control. Activation of this receptor is believed to reduce pro-inflammatory signaling, support cellular repair processes, and enhance nerve regeneration. Its targeted action provides a clean model for studying tissue resilience and inflammatory balance.

Scientific Interest

Researchers are highly interested in ARA-290 due to its ability to separate EPO’s protective benefits from its erythropoietic activity. This distinction allows for focused investigation into nerve health, chronic inflammation, and tissue-repair pathways without unwanted systemic effects.

Research Focus & Clinical Landscape

Key areas of ongoing and emerging research include:

1. – nerve repair and regeneration
2. – neuropathic signaling and sensitivity pathways
3. – inflammation modulation
4. – tissue protection and cellular resilience
5. – small-fiber nerve research
6. – chronic inflammatory conditions

ARA-290 has been evaluated in both preclinical and clinical research settings, particularly in studies involving neuropathy and inflammatory disorders, and continues to gain traction as a targeted regenerative peptide.

Quality, Craftsmanship & Purity

Our ARA-290 is synthesized in GMP-certified facilities and refined to purity levels exceeding >98%. Each batch undergoes rigorous analytical testing to confirm identity, structural precision, and consistent performance, ensuring reliability for advanced research applications.

Final Insight

ARA-290 represents a refined evolution in tissue-protective peptide research — offering a focused, elegant pathway into nerve repair, inflammation control, and cellular resilience without the complexity of full-length hormone activity.